Drug use disorder
Not yet recruitingStudy on Ketamine to Prevent Relapse in Patients with Opioid Use Disorder
- Disease:Drug use disorder
- Substances:Ketamine
Cyprus- Participants:18–64 years · 65+ years
- Substances:Ketamine
- Sponsor:University of Cyprus
Rare diseases
Investigational molecules
Locations
Panepistimiou 1, 2109, Cyprus
The clinical research activity is centered on opioid use disorder, with attention to treatment-resistant symptoms and relapse-related outcomes in individuals receiving maintenance therapy.
Research interest in this area includes clinical strategies that support recovery in patients treated with methadone or buprenorphine/naloxone.
University of Cyprus runs clinical trials in conditions such as Drug use disorder, among others.
Clinical trials registered by this sponsor – none is enrolling right now.
CyprusIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.